Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12168057
IRAK degraders and uses thereof
granted -
US 12168691
VHS format bi-specific antibodies specific for HER2 and VEGF and use thereof
granted -
US 12168648
Opioid receptor modulators
granted -
US 12168009
Modulators of cystic fibrosis transmembrane conductance regulator
granted -
US 12168041
Methods and compositions for CNS delivery of arylsulfatase A
granted -
US 12168023
Inhibitors of adenosine 5′-nucleotidase
granted -
US 12168013
Antiviral prodrugs and nanoformulations thereof
granted -
US 12168036
Methods for treating angiogenic eye disorders with high doses of VEGF receptor fusion proteins
granted -
US 12168071
Treprostinil derivatives and their use in pharmaceutical compositions
granted -
US 12168692
Antibodies targeting CCR2
granted -
US 12168059
Trimeric peptides for antisense delivery
granted -
US 12168688
Antibodies and variants thereof against PD-L1
granted -
US 12168802
Methods of diagnosing and treating CD55 deficiency, hyperactivation of complement, angiopathic thrombosis and protein losing enteropathy (CHAPLE), a newly identified orphan disease
granted -
US 12168008
Oxabicycloheptanes for modulation of immune response
granted -
US 12168681
Il-2 variants with reduced binding to IL-2 receptor alpha and uses thereof
granted -
US 12168054
Method of treating cancer using a combination of entinostat and an anti-CSF-1R antibody
granted -
US 12168056
Scintillator nanocrystal-containing compositions and methods for their use
granted -
US 12170134
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12169199
Activity based host cell protein profiling
granted -
US 12168718
Thermogelling supramolecular sponge as self-healing and biocompatible hydrogel
granted -
US 12168778
Cardiac cell reprogramming with myocardin and ASCL1
granted -
US 12168767
Modified double-stranded RNA agents
granted -
WO 2024252263
COMPOSITIONS SOLIDES DE DICHLORHYDRATE D'ÉLACESTRANT, LEURS PROCÉDÉS DE FABRICATION ET MÉTHODES DE TRAITEMENT LES UTILISANT
granted -
US 12162910
Recombinant gp120 protein with V1-loop deletion
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.